Medical University of South Carolina (MUSC) neurologists have developed a new method based on artificial intelligence that may eventually help both patients and doctors weigh the pros and cons of using brain surgery to treat debilitating seizures caused by epilepsy. This study, which focused on mesial temporal lobe epilepsy (TLE), was published in the September 2018 issue of Epilepsia.

Spinal cord stimulation and physical therapy have helped a man paralyzed since 2013 regain his ability to stand and walk with assistance. The results, achieved in a research collaboration between Mayo Clinic and UCLA, are reported in Nature Medicine. With an implanted stimulator turned on, the man was able to step with a front-wheeled walker while trainers provided occasional assistance.

A new computer program can analyze images of patients' lung tumors, specify cancer types, and even identify altered genes driving abnormal cell growth, a new study shows. Led by researchers at NYU School of Medicine and published online in Nature Medicine, the study found that a type of artificial intelligence (AI), or "machine learning" program, could distinguish with 97 percent accuracy between

Researchers from the Keck School of Medicine of USC are looking to technology to help deconstruct expert surgeons' robotic surgery skills so they can create an objective, standardized way to train the next generation of surgeons. Using a data recorder plugged into a robotic surgery system, the team analyzed expert and novice surgeons' movements during the reconstruction step of robotic radical prostatectomy, a common surgery for prostate cancer.

Sometimes in research, a smaller finding can open the door to big possibilities. Neuroscientists at the University of South Carolina (USC) and the Medical University of South Carolina (MUSC) have collaborated on a study in the field of aphasia that has successfully paved the way for a large clinical trial.

A translational research team led by the National University of Singapore (NUS) has harnessed CURATE.AI, a powerful artificial intelligence (AI) platform, to successfully treat a patient with advanced cancer, completely halting disease progression. This new development represents a big step forward in personalised medicine.

Scientist from King’s College London believe that Artificial Intelligence could hold the key to identifying the best way to treat the country’s biggest killer, coronary heart disease (CHD). And now the team has secured close to £250,000 from by national charity Heart Research UK to pursue the test, that if successful would be less invasive, faster and more cost-effective than existing procedures.